GenMont Biotech Incorporation (TPE:3164)
17.75
+0.05 (0.28%)
At close: Feb 11, 2026
-11.91% (1Y)
| Market Cap | 1.53B -9.3% |
| Revenue (ttm) | 391.48M +6.2% |
| Net Income | 34.49M -35.1% |
| EPS | 0.39 -36.5% |
| Shares Out | 86.01M |
| PE Ratio | 45.52 |
| Forward PE | n/a |
| Dividend | 0.80 (4.52%) |
| Ex-Dividend Date | Mar 27, 2025 |
| Volume | 62,623 |
| Average Volume | 95,527 |
| Open | 17.60 |
| Previous Close | 17.70 |
| Day's Range | 17.50 - 17.75 |
| 52-Week Range | 17.20 - 23.35 |
| Beta | 0.21 |
| RSI | 39.18 |
| Earnings Date | Mar 13, 2026 |